Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Payer profits fell in 2024 as Americans, especially older ones, utilized more medical care. But efforts to resuscitate ...

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.

Each of the six major national insurers turned a profit in the first quarter of 2025, though financial pressures related to ...

Hatzius of Goldman Sachs still puts the chance of a U.S. recession in the next 12 months at 45%. On Tuesday, he cited ...

CVS Health (CVS) stock in focus as Glenview Capital trims a third of its stake after the company's Q1 2025 earnings beat. Read more here.

Renaissance Life & Health Insurance Company of America and Ansel Health are rolling out RenSecureHealth, a new ...